Sign in

CIK 0001534969

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261911522
Phone
+1 801-990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
  1. 4 Open-market sale Chief Information Officer sold 645 shares at $3.13 ($2,019)
  2. 4 Open-market sale Chief Scientific Officer sold 1,395 shares at $3.13 ($4,366)
  3. 4 Open-market sale Chief Financial Officer sold 915 shares at $3.13 ($2,864)
  4. 4/A Planned sale Director sold 1,560 shares at $3.05 ($4,758)
  5. 4 Open-market sale Chief Executive Officer sold 21,158 shares at $3.15 ($66,648)
  6. 4 Open-market sale Chief Financial Officer sold 5,263 shares at $3.15 ($16,578)
  7. 4 Planned sale Director sold 3,899 shares at $3.05 ($11,892)
  8. 4 Planned sale Chief Information Officer sold 2,000 shares at $3.05 ($6,100)
  9. 4 Open-market sale Director sold 222 shares at $3.35 ($744)
  10. 4 Planned sale Chief Data Officer sold 1,458 shares at $3.49 ($5,088)
  11. 4 Planned sale Chief Data Officer sold 10,542 shares at $3.49 ($36,792)
  12. 4 Planned sale Chief Information Officer sold 6,000 shares at $2.22 ($13,320)
  13. 4 Open-market sale Chief Executive Officer sold 8,571 shares at $2.54 ($21,770)
  14. 4 Open-market sale Chief Data Officer sold 6,460 shares at $2.54 ($16,408)
  15. 4 Open-market sale General Counsel sold 6,447 shares at $2.54 ($16,375)
  16. 4 Open-market sale Chief Information Officer sold 5,962 shares at $2.54 ($15,143)
  17. 4 Open-market sale Chief Scientific Officer sold 7,094 shares at $2.54 ($18,019)
  18. 4 Open-market sale Chief Financial Officer sold 5,800 shares at $2.54 ($14,732)
  19. 4 Open-market sale Director sold 225 shares at $2.50 ($563)
  20. 4 Open-market sale Director sold 234 shares at $2.36 ($552)

Page 5 of 16 · 313 filings